Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Quality Index
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Quality Index of -14.96x as of September 2023. Operating cash flow of $-2.05 Million is below net income of $137.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Vanda Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vanda Pharmaceuticals Inc Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Vanda Pharmaceuticals Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Vanda Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Vanda Pharmaceuticals Inc (2010–2023)
Year-by-year earnings quality comparison for Vanda Pharmaceuticals Inc. For live market cap and the full company financial profile, see Vanda Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 5.10x | $12.80 Million | $2.51 Million | ▲ +0.1% |
| 2022 | 5.10x | $31.98 Million | $6.28 Million | ▲ +163.1% |
| 2021 | 1.94x | $64.21 Million | $33.15 Million | ▼ -12.7% |
| 2020 | 2.22x | $51.77 Million | $23.34 Million | ▲ +458.0% |
| 2019 | 0.40x | $45.95 Million | $115.55 Million | ▼ -66.6% |
| 2018 | 1.19x | $29.99 Million | $25.21 Million | ▲ +129.4% |
| 2014 | -4.04x | $-81.55 Million | $20.19 Million | ▼ -166.6% |
| 2010 | -1.52x | $-10.90 Million | $7.19 Million | — |